Schall Law Firm investigates Prestige Consumer Healthcare Inc.
The Schall Law Firm is investigating Prestige Consumer Healthcare Inc. for potential securities law violations following a 4.5% organic revenue decline in fiscal 2026. Shares fell 11.35% after the announcement. Investors are encouraged to contact the firm to discuss their rights.
*this image is generated using AI for illustrative purposes only.
The Schall Law Firm, a national shareholder rights litigation firm, is investigating Prestige Consumer Healthcare Inc. for potential violations of federal securities laws. The investigation focuses on whether the company issued false or misleading statements or failed to disclose material information to investors. This legal scrutiny comes after Prestige released its Q4 and full year 2026 financial results on May 13, 2026.
Prestige reported that for fiscal 2026, revenues decreased 4.5% organically compared to the prior year. The company also stated that its total company adjusted gross margin was 55.6% for the year, approximately flat compared to 55.8% in the previous year. Following this disclosure, shares of Prestige fell by 11.35% on the next trading day.
The Schall Law Firm represents investors globally and specializes in securities class action lawsuits and shareholder rights litigation. Investors who suffered losses in Prestige Consumer Healthcare Inc. are encouraged to contact the firm to discuss their rights. Brian Schall of The Schall Law Firm can be reached at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, or by phone at 310-301-3335.
Key Financial Disclosures
| Metric | Value |
|---|---|
| Organic Revenue Change (FY26) | Decreased 4.5% |
| Adjusted Gross Margin (FY26) | 55.6% |
| Adjusted Gross Margin (Prior Year) | 55.8% |
| Share Price Decline | 11.35% |
Investors can also participate in the investigation through the firm's website at www.schallfirm.com or via email at bschall@schallfirm.com . This press release may be considered Attorney Advertising in some jurisdictions under applicable law and rules of ethics.
What specific material information or statements are regulators likely to scrutinize during the investigation?
How might the ongoing legal uncertainty affect Prestige's ability to retain or attract investors in the short term?
What strategic changes could Prestige implement to reverse the 4.5% organic revenue decline in fiscal 2027?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
